Projects funded by the NCN

Development of optimization methods for dose selection of analgesic drugs used as a combination drug therapy in neuropat...

Call: OPUS 9 , Panel: NZ7

Principal investigator: dr hab. Kinga Sałat

Uniwersytet Jagielloński- Collegium Medicum, Uniwersytet Jagielloński - Collegium Medicum; Wydział Farmaceutyczny

The role of kynurenine pathway in neurophatic pain in view of innovative treatment approaches

Call: SONATA 9 , Panel: NZ4

Principal investigator: dr Ewelina Joanna Rojewska

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Functionalized amino acids - inibitors of GABA uptake with antianalgetic activity

Call: OPUS 8 , Panel: NZ7

Principal investigator: dr Paula Magdalena Zaręba

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

Synthesis, physicochemical and pharmacological properties of new amide derivatives of 3,3-disubstituted pyrrolidine-2,5-...

Call: OPUS 6 , Panel: NZ7

Principal investigator: prof. Jolanta Maria Obniska

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

Neuronal and nonneuronal mechanisms of Bont/A effects in neuropathic pain development - behavioral and biochemical studi...

Call: HARMONIA 5 , Panel: NZ4

Principal investigator: dr hab. Joanna Gabriela Mika

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Activation of endogenous pronociceptive mechanisms of opioid system as an important factors in the development of neurop...

Call: MAESTRO 3 , Panel: NZ4

Principal investigator: prof. Barbara Elżbieta Przewłocka

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Understanding the contribution of immunoproteasome activation to the neuropathic pain development.

Call: OPUS 25 , Panel: NZ7

Principal investigator: dr Natalia Eleonora Małek-Chudzik

Politechnika Wrocławska

The role of simultaneous and individual modulation of μ-opioid, sigma-1 and histamine H3 receptors as a new therapeutic ...

Call: OPUS 23 , Panel: NZ7

Principal investigator: dr Katarzyna Anna Szczepańska

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

New strategies in the pharmacotherapy of neuropathic pain based on modulation of the chemokine system and its influence ...

Call: OPUS 22 , Panel: NZ7

Principal investigator: prof. Joanna Gabriela Mika

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Chronic pain in obesity: from cellular mechanisms to new strategies for targeted therapy.

Call: SONATA 17 , Panel: NZ5

Principal investigator: dr Anna Piotrowska-Murzyn

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

New 3-methoxypropanamide derivatives in search of effective substances for the treatment of neurological diseases - epil...

Call: PRELUDIUM 20 , Panel: NZ7

Principal investigator: Marcin Konrad Jakubiec

Uniwersytet Jagielloński, Collegium Medicum

Selective inhibitors of γ-aminobutyric acid (GABA) transporter subtype 3 (GAT3) as a new pharmacological tools and a cha...

Call: OPUS 21 , Panel: NZ7

Principal investigator: dr Dawid Marcin Panek

Uniwersytet Jagielloński, Collegium Medicum

Exploring new drug targets for efficacious therapy of neuropathic pain basing on the assessment and modulation of neuroi...

Call: OPUS 2 , Panel: NZ4

Principal investigator: dr hab. Joanna Gabriela Mika

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Dual histamine H3 and sigma-1 receptor ligands as novel pharmacological tools in the treatment of central nervous system...

Call: SONATINA 4 , Panel: NZ7

Principal investigator: Katarzyna Anna Szczepańska

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Pharmacological modulation of histamine H3 and H4 receptors - a new perspective in the treatment of neuropathic pain

Call: SONATA 15 , Panel: NZ7

Principal investigator: dr Katarzyna Popiołek-Barczyk

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

New strategies in neuropathic pain pharmacotherapy based on the modulation of the functions of chemokine receptors CCR2 ...

Call: PRELUDIUM 15 , Panel: NZ7

Principal investigator: dr Klaudia Kwiatkowski

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Opioid-induced analgesia and hyperalgesia in neuropathic pain - mechanisms and druggable targets

Call: OPUS 15 , Panel: NZ7

Principal investigator: prof. Barbara Elżbieta Przewłocka

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Multifunctional ligands - TRPA1 channel antagonists and phosphodiesterases inhibitors as a new approach for the treatmen...

Call: OPUS 15 , Panel: NZ7

Principal investigator: prof. Grażyna Chłoń-Rzepa

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

Novel hybrid compounds derived from pyrrolidine-2,5-dione or imidazolidine-2,4-dione scaffold and their effect on centra...

Call: OPUS 13 , Panel: NZ7

Principal investigator: dr hab. Krzysztof Tomasz Kamiński

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

Determination of the mechanisms and potential targets for neuropathic pain therapy by investigating pharmacological inte...

Call: PRELUDIUM 12 , Panel: NZ7

Principal investigator: Anna Piotrowska-Murzyn

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Search for new targets for an effective therapy of neuropathic pain and enhancement of opioids effects basing on the exa...

Call: OPUS 11 , Panel: NZ4

Principal investigator: prof. Joanna Gabriela Mika

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk